| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.2 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.08 | 0.2 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |